Statewide Prevention and Control Trainings for Long-Term Care Infection Preventionists; CMS Launches MAHA Elevate Initiative Targeting Chronic Disease; FDA Expands Infant Botulism Outbreak Caused by ByHeart Baby Formula;  Early Alert: Anesthesia System Issue from GE HealthCare
View in browser
IHA-logo
IHA Emails_Daily Briefing

Friday, December 12, 2025

Today's Top Stories

  • Statewide Prevention and Control Trainings for Long-Term Care Infection Preventionists
  • CMS Launches MAHA Elevate Initiative Targeting Chronic Disease
  • FDA Expands Infant Botulism Outbreak Caused by ByHeart Baby Formula
  • Early Alert: Anesthesia System Issue from GE HealthCare
  • Illinois Respiratory Disease Surveillance Data
  • Briefly Noted
  • Leading the News

Statewide Prevention and Control Trainings for Long-Term Care Infection Preventionists
The Hektoen Institute of Medicine, with funding from the Illinois Dept. of Public Health, is hosting three-day Infection Prevention and Control classes specifically designed for infection preventionists working in long-term care facilities across Illinois. In light of evolving challenges in infection control, ensuring staff remain equipped with the most current knowledge and best practices is critical.
 
The classes will be held in various cities across Illinois to ensure long-term care infection preventionists in all regions can participate. Click here to access additional information, including class objectives and registration links for available dates and locations.
 
Questions can be directed to Rachel.Simon@Hektoen.org.
 
CMS Launches MAHA Elevate Initiative Targeting Chronic Disease
The Centers for Medicare & Medicaid Services (CMS) unveiled the “Make America Healthy Again: Enhancing Lifestyle and Evaluating Value-based Approaches Through Evidence,” or Elevate, model. The initiative will fund up to 30 proposals promoting health and prevention for original Medicare beneficiaries. The proposals will utilize evidence-based, whole-person care approaches currently not covered by original Medicare, such as nutrition, physical activity, sleep, stress management, harmful substance avoidance and social connections. Awardees will be required to collect quality and cost data. CMS said the “approaches are intended to support, not replace, the medical care received by people with Medicare.” CMS will release a Notice of Funding Opportunity in early 2026 for the first cohort, and the voluntary model will launch on Sept. 1, 2026.
 
FDA Expands Infant Botulism Outbreak Caused by ByHeart Baby Formula 
This week, the Food and Drug Administration (FDA) expanded an outbreak of infant botulism caused by recalled ByHeart baby formula. The update said the “FDA cannot rule out the possibility that contamination might have affected all ByHeart formula products.” In response, the Centers for Disease Control and Prevention (CDC) has broadened the case definition to include any infant with botulism who was exposed to ByHeart formula at any time since the product’s release in March 2022. As of Dec. 10, a total of 51 infants with suspected or confirmed infant botulism and confirmed exposure to ByHeart Whole Nutrition infant formula have been reported from 19 states, including Illinois. A Dec. 10 CDC update offers clinician guidance.
 
Early Alert: Anesthesia System Issue from GE HealthCare
The Food and Drug Administration (FDA) has issued an Early Alert notice to alert the public that GE HealthCare has issued updated use instructions for certain Carestation 600 and 700 series Anesthesia Systems due to the potential for an unexpected shutdown if the AC mains power is unplugged or experiences a loss of power. GE HealthCare said that when using affected devices, it critical to ensure the device has a secure connection to an AC mains power source, noting that in certain circumstances a power failure may lead to a life-threating loss of ventilation. As of Nov. 26, GE HealthCare has not reported any serious injuries or deaths associated with this issue.
 

Illinois Respiratory Disease Surveillance Data

 

The Infectious Respiratory Disease Surveillance Dashboard from the Illinois Dept. of Public Health (IDPH) provides the latest data on hospital visits, seasonal trends, lab test positivity and demographic data. IDPH also tracks COVID-19, influenza and respiratory syncytial virus information through the Illinois Wastewater Surveillance System dashboard.

 

Briefly Noted

 

The Food and Drug Administration (FDA) this week approved a U.S.-manufactured version of the antibiotic Augmentin XR (amoxicillin-clavulanate potassium) under the Commissioner's National Priority Voucher pilot program, which seeks to expedite approval of drugs that address critical national health priorities. This is the first approval under the program, which was launched in June. FDA officials said the approval was completed within two months, as compared to a typical FDA review of drug applications, which typically takes 10 to 12 months.

 

Leading the News

 

Advocates, opponents seek to sway Gov. JB Pritzker on medical aid in dying legislation passed by Illinois General Assembly

CBS 2

Illinois could soon join a growing list of states where terminally ill patients would be allowed to take life-ending medication prescribed by a doctor. Pritzker has not said if he'll sign it, and the controversial legislation has people on both sides trying to bend the governor's ear.

 

New laws: Gun storage, police background check changes take effect in 2026

WUIS

Gun owners in Illinois must take new steps in 2026 to secure their firearms in their homes, particularly when children are present.

 

Nasal spray sold nationwide recalled due to mold, ‘life-threatening' infections possible, FDA says

NBC 5

A popular nasal spray sold at retailers nationwide is being recalled because it was found to contain mold and microbial contamination, with customers urged to "immediately" discontinue using the product.

IHA News
IHA Events

Questions or Comments?
Want to subscribe? Contact us at: iha@team-iha.org

Facebook
LinkedIn
X

www.team-iha.org

©2026 Illinois Health and Hospital Association

 PO Box 3015

Naperville, IL 60566

(630) 276-5400

 

Unsubscribe   Manage Preferences